STMN1 seems to be a crucial factor in CRC metastasis, making it a promising biomarker for prognosis (higher STMN1 expression is linked to worse survival outcomes in CRC patients) and a potential therapeutic target [65]. The gene discussed is STMN1; the disease is colorectal carcinoma.